Plasma Blast Freezer

Name: Plasma Blast Freezer - Amaris Medical Solutions
Price: 1.00 USD
Availability: InStock

$1.00

WhatsApp Order

A Plasma Blast Freezer is a specialized Class II medical device designed for the rapid freezing of fresh frozen plasma (FFP), cryoprecipitate, and source plasma in blood banking and transfusion medicine. Operating at -30°C to -50°C with high-velocity forced-air circulation, these units achieve core temperatures of -30°C in plasma units within 60-90 minutes, preserving labile coagulation factors (Factor V, Factor VIII) and meeting stringent AABB, FDA, CAP, and EU regulatory requirements. Available in benchtop (10-30 unit) and floor (50-200+ unit) configurations with stainless steel construction, programmable microprocessor controls, multi-point temperature monitoring with product simulators, continuous data logging, and multi-level alarm systems. Primary clinical applications include rapid freezing of fresh frozen plasma (within 8-24 hours of collection), cryoprecipitate production, source plasma freezing for fractionation, controlled-rate freezing of blood components, research applications, emergency preparedness, and biobanking preparation. Critical safety requirements include validated freezing cycles, temperature mapping, redundant monitoring, documented freezing curves, and strict adherence to regulatory standards for plasma component quality and patient safety.

Compare

Add to wishlist

Categories: LABORATORY EQUIPMENT AND SUPPLIES, HOME HEALTHCARE AND DURABLE MEDICAL EQUIPMENT (DME), Monitoring Devices, Refrigerators, Freezers, and Storage Units Tags: AABB Compliant, Blast Freezer, Blood Bank Freezer, Cryoprecipitate Production, FFP Freezer, Plasma Blast Freezer, Plasma Quick Freezer, Rapid Plasma Freezer, Source Plasma Freezing, Transfusion Medicine

Description

Plasma Blast Freezer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Rapid Freezing of Fresh Frozen Plasma (FFP):

Primary Use: Plasma blast freezers are specifically designed to rapidly freeze fresh plasma to core temperatures of -30°C or colder within 60-90 minutes, preserving labile coagulation factors (Factor V, Factor VIII) and maintaining therapeutic efficacy of plasma for transfusion.
How it helps: Preserves the delicate clotting factors that trauma patients and those with bleeding disorders desperately need, ensuring that when plasma is thawed for transfusion, it still contains all the components required to stop bleeding.

2. Cryoprecipitate Production:

Primary Use: Rapid freezing is essential for cryoprecipitate manufacturing, as the controlled freezing process affects the yield and quality of Factor VIII, von Willebrand factor, fibrinogen, and Factor XIII in the final cryoprecipitate product.
How it helps: Maximizes the recovery of concentrated clotting factors from plasma, ensuring that patients with hemophilia and other bleeding disorders receive the most effective treatment possible from every donation.

3. Freezing of Source Plasma for Fractionation:

Primary Use: Used in plasma fractionation facilities to rapidly freeze large volumes of source plasma (500 mL to 1 L bags) for subsequent manufacturing of albumin, immunoglobulins, and clotting factor concentrates.
How it helps: Supports the large-scale production of plasma-derived medications that treat everything from immune deficiencies to neurological disorders, making these life-saving treatments available to patients worldwide.

4. Controlled-Rate Freezing of Blood Components:

Primary Use: Ensures consistent, reproducible freezing rates for blood components, meeting AABB, FDA, and EU regulatory requirements for plasma freezing and storage.
How it helps: Guarantees that every unit of frozen plasma meets the same high quality standards, regardless of when or where it was processed, giving clinicians confidence in the products they transfuse.

5. Research and Development Applications:

Primary Use: Used in transfusion medicine research to study freezing protocols, cryopreservation techniques, and the effects of freezing rates on plasma protein stability and function.
How it helps: Advances our understanding of how to better preserve blood components, leading to improved products and better outcomes for patients who depend on transfusions.

6. Emergency Preparedness and Mass Casualty Response:

Primary Use: Enables rapid freezing of large plasma inventories for emergency preparedness, ensuring availability of fresh frozen plasma for trauma, burn, and massive transfusion protocols.
How it helps: Prepares communities for disasters by building reserves of frozen plasma that can be rapidly deployed when mass casualty events strain local blood supplies.

7. Biobanking and Long-Term Storage Preparation:

Primary Use: Prepares plasma samples for long-term biobanking by rapid freezing to preserve analytes and prevent degradation during subsequent storage at -20°C to -80°C.
How it helps: Creates high-quality biological repositories that researchers can use for years to study diseases, discover biomarkers, and develop new treatments.

SECONDARY & SUPPORTIVE USES

1. Freezing of Research Samples: Rapid freezing of research plasma samples for proteomics, metabolomics, and biomarker studies requiring preservation of labile compounds, supporting scientific discovery.

2. Pharmaceutical and Biologic Manufacturing: Used in manufacturing processes requiring rapid freezing of bulk biological materials, supporting the production of life-saving medications.

3. Veterinary Blood Banking: Freezing of animal plasma for veterinary transfusion medicine applications, extending the benefits of modern medicine to animals.

4. Cell and Tissue Banking: Some units may be used for controlled-rate freezing of cells and tissues (with appropriate validation), supporting regenerative medicine and research.

5. Quality Control and Validation Studies: Used to validate freezing protocols and equipment performance in blood bank quality assurance programs, ensuring ongoing quality and safety.

6. Training and Education: Used in blood bank training programs to demonstrate proper plasma freezing techniques, building the skills of future transfusion medicine professionals.

7. Disaster Response Preparedness: Maintained in strategic locations for rapid plasma freezing during public health emergencies, ensuring communities are ready for crises.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Product Type: Specialized rapid-freezing equipment designed to quickly freeze plasma to core temperatures of -30°C or below for blood banking and transfusion medicine applications.
Common Names: Plasma Blast Freezer, Blast Freezer, Rapid Plasma Freezer, Plasma Quick Freezer, Shock Freezer, Flash Freezer.
Temperature Range: Typically -30°C to -50°C operating temperature; capable of achieving core temperature of -30°C within 60-90 minutes.
Freezing Capacity: 10-200 plasma units per cycle depending on model and configuration.
Freezing Technology: Forced-air convection with high-velocity fans or direct contact freezing plates.
Control System: Microprocessor controller with programmable freezing cycles, temperature profiling, and data logging.
Temperature Monitoring: Multi-point temperature monitoring with sensors in product simulators or representative units.
Alarm System: Audible and visual alarms for temperature deviations, cycle completion, and system malfunctions.
Validation: Validated freezing cycles with documentation for regulatory compliance (AABB, FDA, EU).
Power Requirements: 200-240 VAC, 50/60 Hz, dedicated circuit required; some larger units require 3-phase power.
Construction: Stainless steel interior and exterior for durability and easy cleaning; high-density insulation.

2. TECHNICAL & PERFORMANCE PROPERTIES

Freezing Temperature: -30°C to -50°C cabinet temperature; capable of achieving -30°C core temperature in plasma units.
Freezing Time: 60-90 minutes to reach core temperature of -30°C (varies by unit size, load, and starting temperature).
Temperature Uniformity: ±2-3°C throughout the freezing chamber with forced-air circulation.
Freezing Capacity: 10-200 plasma units per cycle (typical ranges: 10-30 units benchtop; 50-200 units floor models).
Loading Configurations: Shelving systems, racks, or baskets designed for standard plasma bags (250 mL, 500 mL, 1 L).
Air Flow: High-velocity, directional air flow for rapid heat transfer; pre-cooled air circulation.
Defrost Cycle: Automatic defrost with enhanced condensate management; cycles timed to minimize temperature impact.
Temperature Profiling: Ability to program and document complete freezing curves for validation.
Data Logging: Continuous temperature recording with audit trail for regulatory compliance.
Alarm Systems: Multi-level alarms for temperature excursions, cycle completion, and equipment status.
Validation Ports: Access ports for insertion of calibrated temperature sensors for validation studies.

3. PHYSICAL & OPERATIONAL PROPERTIES

Dimensions: Varies by capacity: benchtop units 80-120 cm W × 70-90 cm D × 100-150 cm H; floor models larger.
Interior Volume: 100-1,000+ liters depending on model.
Construction: Stainless steel interior and exterior (medical grade); insulated with high-density polyurethane.
Door Configuration: Solid insulated doors with magnetic gaskets; some models with inner glass doors for viewing.
Shelving/Racking: Adjustable stainless steel shelves or specialized plasma bag racks; pull-out drawer systems.
Loading Systems: Roller racks, pull-out baskets, or fixed shelving designed for plasma bag configurations.
Interior Lighting: LED interior lighting for easy loading and unloading.
Noise Level: 55-70 dB depending on model and fan operation.
Power Requirements: 200-240 VAC, 50/60 Hz, dedicated circuit; larger units may require 3-phase power.
Refrigeration System: Heavy-duty compressor system with rapid cool-down and recovery; some units with dual compressors.
Certifications: UL/cUL, CE, ISO 13485 compliant manufacturing; AABB guidelines compliance.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: Class II medical device (FDA, CE marked); must meet AABB, CAP, and FDA blood bank standards for plasma freezing.
Safety Standards: Complies with UL 471 and CSA C22.2 for commercial refrigerators/freezers; IEC 61010-2-011.
Temperature Alarm: Audible and visual alarms for temperature deviations (user-settable limits).
Cycle Completion Alarm: Indicates when the freezing cycle is complete and products can be transferred to storage.
Remote Alarm Contacts: Dry contacts for connection to building management systems.
Temperature Monitoring: Multi-point monitoring with sensors in product simulators; continuous data logging.
Validation: Pre-programmed validated freezing cycles with documentation; temperature mapping required.
Quality Management: Manufactured under ISO 13485 certified processes.
Refrigerant: Environmentally friendly, CFC-free refrigerants.
Emergency Backup: Battery backup for alarm and monitoring system; generator compatibility.
Data Logging: 21 CFR Part 11 compliant data logging available (select models).
Audit Trail: Electronic records of all freezing cycles, alarms, and operator actions.

5. STORAGE & HANDLING ATTRIBUTES

Installation: Professional installation required; place on level, stable surface; adequate ventilation clearance; dedicated power circuit.
Pre-Cooling: Allow 2-4 hours for the unit to reach operating temperature before first use.
Loading: Load plasma units in single layers with space between bags for air circulation; avoid overloading.
Temperature Monitoring: Use validated product simulators or representative units for temperature verification.
Cycle Documentation: Record freezing curves, temperatures, and cycle completion for each batch.
Cleaning: Regular cleaning with mild detergent and water; disinfect with appropriate agents; avoid abrasive cleaners.
Defrosting: Automatic defrost cycles; monitor condensate drainage.
Calibration: Annual temperature calibration verification required; documented for regulatory compliance.
Validation: Initial validation and periodic revalidation of freezing cycles; temperature mapping.
Maintenance: Regular preventive maintenance per manufacturer schedule; documented service records.
Emergency Procedures: Documented plan for freezer failure and product transfer to backup storage.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: Rapid freezing of plasma for transfusion medicine, meeting AABB, FDA, and EU regulatory requirements for fresh frozen plasma production.
Fresh Frozen Plasma (FFP) Production (AABB Standards):
- Freezing Requirement: Achieve core temperature of -18°C or colder (typically -30°C) within timeframes specified by regulatory standards.
- Timing: Plasma must be frozen within 8 hours of collection (standard FFP) or 24 hours (FP24).
- Freezing Rate: Rapid freezing preserves labile coagulation factors (Factor V, Factor VIII).
- Temperature Monitoring: Documented freezing curves with product simulators.
- Validation: Validated freezing cycles with temperature mapping.
Cryoprecipitate Manufacturing:
- Freezing Process: Rapid freezing essential for optimal cryoprecipitate yield.
- Thawing: Controlled thawing at 1-6°C for cryoprecipitate production.
- Quality Control: Freezing rate affects Factor VIII and fibrinogen recovery.
Source Plasma Freezing:
- Volume: 500 mL to 1 L bags for fractionation.
- Freezing: Rapid freezing to maintain protein integrity for downstream manufacturing.
- Documentation: Complete freezing records for regulatory compliance.
Regulatory Compliance:
- AABB Standards: Standards for Blood Banks and Transfusion Services (plasma freezing requirements).
- FDA: 21 CFR 600-800 regulations for blood components; 21 CFR 211 for GMP manufacturing.
- CAP: College of American Pathologists accreditation requirements.
- EU Guidelines: EU Blood Directive requirements for plasma freezing.
- Pharmaceutical Guidelines: May apply for source plasma used in fractionation.
Capacity Planning:
- Throughput: Match freezer capacity to daily plasma collection volume.
- Batch Processing: Organize freezing cycles by collection time and type (FFP vs. FP24).
- Storage Transfer: Plan for transfer from blast freezer to long-term storage freezer.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Regulatory Compliance: Must meet AABB, FDA, and CAP standards for plasma freezing; regular inspections and audits.
Temperature Monitoring: Use validated product simulators for each freeze cycle; document complete freezing curves.
Cycle Validation: Initial validation and periodic revalidation of freezing cycles required; document all parameters.
Loading Procedures: Follow validated loading patterns; do not overload or block air flow.
Door Management: Minimize door openings during cooling; fully close between loads.
Product Handling: Pre-cool plasma at 1-6°C before freezing when indicated; document pre-freeze temperatures.
Expiration Dating: Freezing date establishes expiration (typically 12 months for FFP at -18°C).
Power Outage: Emergency plan with backup power; monitor temperatures during outage.
Spill Cleanup: Blood bag breakage requires special handling; use PPE; follow biohazard protocols.
Training: All staff must be trained on freezer operation, loading procedures, and alarm response; documented training.
Documentation: Complete records of all freezing cycles, temperatures, and alarms for regulatory compliance.
Maintenance: Regular preventive maintenance by qualified technicians; documented service records.

2. FIRST AID MEASURES

Temperature Excursion During Freezing: Evaluate if cycle can be completed; if not, remove products and reassign for alternative use (e.g., fractionation rather than transfusion). Document excursion fully.
Power Failure During Cycle: Monitor chamber temperature; if prolonged, transfer products to a validated backup unit. Document all actions.
Blood Bag Breakage During Loading: Wear appropriate PPE. Carefully remove intact bags; contain spill. Disinfect area with 10% bleach solution; dispose of biohazard waste.
Refrigerant Leak: Evacuate area; ventilate; call facility maintenance; follow refrigerant safety protocols.
Freezer Failure: Activate emergency transfer plan; move products to validated backup freezer. Document temperatures; notify blood bank medical director.
Personal Injury (Cold Burns): Warm affected area gradually with lukewarm water (not hot); seek medical attention if severe.

3. FIRE FIGHTING MEASURES

Flammability: Refrigerants may be flammable (check specifications); electrical components combustible.
Extinguishing Media: For electrical fire, use CO₂ or dry chemical (Class C) extinguisher; CO₂ preferred.
Power Off: Disconnect power if safe to do so; emergency shutoff accessible.
Refrigerant Fire: Some refrigerants may produce toxic gases; use SCBA in enclosed spaces.
Evacuation: Evacuate area; follow facility fire protocols.
Product Protection: If safe, protect plasma products from heat and smoke; assess usability per medical director.

Plasma Blast Freezer

Plasma Blast Freezer

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Rapid Freezing of Fresh Frozen Plasma (FFP):

Primary Use: Plasma blast freezers are specifically designed to rapidly freeze fresh plasma to core temperatures of -30°C or colder within 60-90 minutes, preserving labile coagulation factors (Factor V, Factor VIII) and maintaining therapeutic efficacy of plasma for transfusion.

How it helps: Preserves the delicate clotting factors that trauma patients and those with bleeding disorders desperately need, ensuring that when plasma is thawed for transfusion, it still contains all the components required to stop bleeding.

2. Cryoprecipitate Production:

Primary Use: Rapid freezing is essential for cryoprecipitate manufacturing, as the controlled freezing process affects the yield and quality of Factor VIII, von Willebrand factor, fibrinogen, and Factor XIII in the final cryoprecipitate product.

How it helps: Maximizes the recovery of concentrated clotting factors from plasma, ensuring that patients with hemophilia and other bleeding disorders receive the most effective treatment possible from every donation.

3. Freezing of Source Plasma for Fractionation:

Primary Use: Used in plasma fractionation facilities to rapidly freeze large volumes of source plasma (500 mL to 1 L bags) for subsequent manufacturing of albumin, immunoglobulins, and clotting factor concentrates.

How it helps: Supports the large-scale production of plasma-derived medications that treat everything from immune deficiencies to neurological disorders, making these life-saving treatments available to patients worldwide.

4. Controlled-Rate Freezing of Blood Components:

Primary Use: Ensures consistent, reproducible freezing rates for blood components, meeting AABB, FDA, and EU regulatory requirements for plasma freezing and storage.

How it helps: Guarantees that every unit of frozen plasma meets the same high quality standards, regardless of when or where it was processed, giving clinicians confidence in the products they transfuse.

5. Research and Development Applications:

Primary Use: Used in transfusion medicine research to study freezing protocols, cryopreservation techniques, and the effects of freezing rates on plasma protein stability and function.

How it helps: Advances our understanding of how to better preserve blood components, leading to improved products and better outcomes for patients who depend on transfusions.

6. Emergency Preparedness and Mass Casualty Response:

Primary Use: Enables rapid freezing of large plasma inventories for emergency preparedness, ensuring availability of fresh frozen plasma for trauma, burn, and massive transfusion protocols.

How it helps: Prepares communities for disasters by building reserves of frozen plasma that can be rapidly deployed when mass casualty events strain local blood supplies.

7. Biobanking and Long-Term Storage Preparation:

Primary Use: Prepares plasma samples for long-term biobanking by rapid freezing to preserve analytes and prevent degradation during subsequent storage at -20°C to -80°C.

How it helps: Creates high-quality biological repositories that researchers can use for years to study diseases, discover biomarkers, and develop new treatments.

SECONDARY & SUPPORTIVE USES

1. Freezing of Research Samples: Rapid freezing of research plasma samples for proteomics, metabolomics, and biomarker studies requiring preservation of labile compounds, supporting scientific discovery.

2. Pharmaceutical and Biologic Manufacturing: Used in manufacturing processes requiring rapid freezing of bulk biological materials, supporting the production of life-saving medications.

3. Veterinary Blood Banking: Freezing of animal plasma for veterinary transfusion medicine applications, extending the benefits of modern medicine to animals.

4. Cell and Tissue Banking: Some units may be used for controlled-rate freezing of cells and tissues (with appropriate validation), supporting regenerative medicine and research.

5. Quality Control and Validation Studies: Used to validate freezing protocols and equipment performance in blood bank quality assurance programs, ensuring ongoing quality and safety.

6. Training and Education: Used in blood bank training programs to demonstrate proper plasma freezing techniques, building the skills of future transfusion medicine professionals.

7. Disaster Response Preparedness: Maintained in strategic locations for rapid plasma freezing during public health emergencies, ensuring communities are ready for crises.

1. BASIC IDENTIFICATION ATTRIBUTES

Product Type: Specialized rapid-freezing equipment designed to quickly freeze plasma to core temperatures of -30°C or below for blood banking and transfusion medicine applications.

Common Names: Plasma Blast Freezer, Blast Freezer, Rapid Plasma Freezer, Plasma Quick Freezer, Shock Freezer, Flash Freezer.

Temperature Range: Typically -30°C to -50°C operating temperature; capable of achieving core temperature of -30°C within 60-90 minutes.

Freezing Capacity: 10-200 plasma units per cycle depending on model and configuration.

Freezing Technology: Forced-air convection with high-velocity fans or direct contact freezing plates.

Control System: Microprocessor controller with programmable freezing cycles, temperature profiling, and data logging.

Temperature Monitoring: Multi-point temperature monitoring with sensors in product simulators or representative units.

Alarm System: Audible and visual alarms for temperature deviations, cycle completion, and system malfunctions.

Validation: Validated freezing cycles with documentation for regulatory compliance (AABB, FDA, EU).

Power Requirements: 200-240 VAC, 50/60 Hz, dedicated circuit required; some larger units require 3-phase power.

Construction: Stainless steel interior and exterior for durability and easy cleaning; high-density insulation.

2. TECHNICAL & PERFORMANCE PROPERTIES

Freezing Temperature: -30°C to -50°C cabinet temperature; capable of achieving -30°C core temperature in plasma units.

Freezing Time: 60-90 minutes to reach core temperature of -30°C (varies by unit size, load, and starting temperature).

Temperature Uniformity: ±2-3°C throughout the freezing chamber with forced-air circulation.

Freezing Capacity: 10-200 plasma units per cycle (typical ranges: 10-30 units benchtop; 50-200 units floor models).

Loading Configurations: Shelving systems, racks, or baskets designed for standard plasma bags (250 mL, 500 mL, 1 L).

Air Flow: High-velocity, directional air flow for rapid heat transfer; pre-cooled air circulation.

Defrost Cycle: Automatic defrost with enhanced condensate management; cycles timed to minimize temperature impact.

Temperature Profiling: Ability to program and document complete freezing curves for validation.

Data Logging: Continuous temperature recording with audit trail for regulatory compliance.

Alarm Systems: Multi-level alarms for temperature excursions, cycle completion, and equipment status.

Validation Ports: Access ports for insertion of calibrated temperature sensors for validation studies.

3. PHYSICAL & OPERATIONAL PROPERTIES

Dimensions: Varies by capacity: benchtop units 80-120 cm W × 70-90 cm D × 100-150 cm H; floor models larger.

Interior Volume: 100-1,000+ liters depending on model.

Construction: Stainless steel interior and exterior (medical grade); insulated with high-density polyurethane.

Door Configuration: Solid insulated doors with magnetic gaskets; some models with inner glass doors for viewing.

Shelving/Racking: Adjustable stainless steel shelves or specialized plasma bag racks; pull-out drawer systems.

Loading Systems: Roller racks, pull-out baskets, or fixed shelving designed for plasma bag configurations.

Interior Lighting: LED interior lighting for easy loading and unloading.

Noise Level: 55-70 dB depending on model and fan operation.

Power Requirements: 200-240 VAC, 50/60 Hz, dedicated circuit; larger units may require 3-phase power.

Refrigeration System: Heavy-duty compressor system with rapid cool-down and recovery; some units with dual compressors.

Certifications: UL/cUL, CE, ISO 13485 compliant manufacturing; AABB guidelines compliance.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: Class II medical device (FDA, CE marked); must meet AABB, CAP, and FDA blood bank standards for plasma freezing.

Safety Standards: Complies with UL 471 and CSA C22.2 for commercial refrigerators/freezers; IEC 61010-2-011.

Temperature Alarm: Audible and visual alarms for temperature deviations (user-settable limits).

Cycle Completion Alarm: Indicates when the freezing cycle is complete and products can be transferred to storage.

Remote Alarm Contacts: Dry contacts for connection to building management systems.

Temperature Monitoring: Multi-point monitoring with sensors in product simulators; continuous data logging.

Validation: Pre-programmed validated freezing cycles with documentation; temperature mapping required.

Quality Management: Manufactured under ISO 13485 certified processes.

Refrigerant: Environmentally friendly, CFC-free refrigerants.

Emergency Backup: Battery backup for alarm and monitoring system; generator compatibility.

Data Logging: 21 CFR Part 11 compliant data logging available (select models).